{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:30:05Z","timestamp":1768321805557,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jcv.2016.09.011","type":"journal-article","created":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T10:12:32Z","timestamp":1475835152000},"page":"74-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Effectiveness of HPV vaccination in women reaching screening age in Italy"],"prefix":"10.1016","volume":"84","author":[{"given":"F.M.","family":"Carozzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3454-261X","authenticated-orcid":false,"given":"C.","family":"Ocello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Burroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Faust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Paci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Iossa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Confortini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2016.09.011_bib0005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2016.09.011_bib0010","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Females united to unilaterally reduce endo\/ectocervical disease (FUTURE) I investigators: quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2016.09.011_bib0015","doi-asserted-by":"crossref","first-page":"238","DOI":"10.5694\/j.1326-5377.2008.tb01593.x","article-title":"Human papillomavirus vaccination for the prevention of cervical neoplasia: is it appropriate to vaccinate women older than 26?","volume":"188","author":"Skinner","year":"2008","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.jcv.2016.09.011_bib0020","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.vaccine.2009.01.035","article-title":"Literature review of human papillomavirus vaccine acceptability among women over 26 years","volume":"27","author":"Black","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.jcv.2016.09.011_bib0025","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1002\/ijc.30035","article-title":"Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: a population-based study","volume":"138","author":"Herweijer","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2016.09.011_bib0030","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/ijc.25915","article-title":"Eurogin 2010 roadmap on cervical cancer prevention","volume":"128","author":"Franceschi","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2016.09.011_bib0035","unstructured":"X. Castellsagu\u00e9, L. Bruni, S. de Sanojose, F.X. Bosch, Other potential indications and targets for HPV vaccination: the case of mid-adult women. EUROGIN Congress 2013, Florence, Italy; November 3\u20135, 2013. Report No SS23-4 (abstr)."},{"key":"10.1016\/j.jcv.2016.09.011_bib0040","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/jmv.24085","article-title":"Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening","volume":"87","author":"Burroni","year":"2015","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2016.09.011_bib0045","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4161\/hv.24337","article-title":"Evaluation of bivalent human papillomavirus (HPV) vaccine safety and tolerability in a sample of 25\u2009year old Tuscan women","author":"Levi","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"issue":"Pt B","key":"10.1016\/j.jcv.2016.09.011_bib0050","first-page":"1","article-title":"IARC Working Group on the evaluation of carcinogenic risks to humans. biological agents. Volume 100 B. a review of human carcinogens","volume":"100","year":"2012","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"issue":"Pt 7","key":"10.1016\/j.jcv.2016.09.011_bib0055","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1099\/vir.0.019349-0","article-title":"Validation of multiplexed human papillomavirus serology using pseudovirions bound to heparin-coated beads","volume":"91","author":"Faust","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jcv.2016.09.011_bib0060","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jcv.2012.12.004","article-title":"Serum antibodies to human papillomavirus (HPV) pseudovirions correlate with natural infection for 13 genital HPV types","volume":"56","author":"Faust","year":"2013","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2016.09.011_bib0065","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.vaccine.2011.10.096","article-title":"International collaborative proficiency study of Human Papillomavirus type 16 serology","volume":"30","author":"Eklund","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2016.09.011_bib0070","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.4161\/hv.24340","article-title":"Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica vaccine trial","volume":"9","author":"Safaeian","year":"2013","journal-title":"Hum. Vaccine Immunother."},{"key":"10.1016\/j.jcv.2016.09.011_bib0075","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","article-title":"Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Wheeler","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcv.2016.09.011_bib0080","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1473-3099(12)70187-1","article-title":"Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis","volume":"12","author":"Malag\u00f3n","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jcv.2016.09.011_bib0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1473-3099(13)70024-0","article-title":"Cross protection against HPV might prevent type replacement","volume":"13","author":"Verdenius","year":"2013","journal-title":"Lancet Infect. Dis."},{"issue":"11 May","key":"10.1016\/j.jcv.2016.09.011_bib0090","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1038\/bjc.2014.198","article-title":"Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16\/18 and closely related HPV types","volume":"110","author":"Kavanagh","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jcv.2016.09.011_bib0095","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/infdis\/jit192","article-title":"Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003\u20132010","volume":"208","author":"Markowitz","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2016.09.011_bib0100","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1542\/peds.2011-3587","article-title":"Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction","volume":"130","author":"Kahn","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcv.2016.09.011_bib0105","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S1473-3099(13)70302-5","article-title":"HPV genotype replacement: too early to tell","volume":"13","author":"Pons-Salort","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jcv.2016.09.011_bib0110","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.4161\/hv.7.12.18282","article-title":"Comparison of the immunogenicity of the human papillomavirus (HPV)-16\/18 vaccine and the HPV-6\/11\/16\/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18\u201345 years","volume":"7","author":"Einstein","year":"2011","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.jcv.2016.09.011_bib0115","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4161\/hv.7.12.18322","article-title":"Immunogenicity and safety of the HPV-16\/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: results from a randomized study","volume":"7","author":"Romanowski","year":"2011","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.jcv.2016.09.011_bib0120","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4161\/hv.7.12.18281","article-title":"Comparative immunogenicity and safety of human papillomavirus (HPV)-16\/18 vaccine and HPV-6\/11\/16\/18 vaccine: follow-up from months 12\u201324 in a Phase III randomized study of healthy women aged 18\u201345 years","volume":"7","author":"Einstein","year":"2011","journal-title":"Hum. Vaccine"},{"key":"10.1016\/j.jcv.2016.09.011_bib0125","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fonc.2013.00328","article-title":"Comparison of antibody responses to human papillomavirus vaccination as measured by three assays","volume":"3","author":"Robbins","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jcv.2016.09.011_bib0130","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.4161\/hv.28022","article-title":"Immune response to the HPV-16\/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination: results from a randomized study","volume":"10","author":"Romanowski","year":"2014","journal-title":"Hum. Vaccine Immunother."},{"key":"10.1016\/j.jcv.2016.09.011_bib0135","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1158\/1940-6207.CAPR-13-0203","article-title":"Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica vaccine trial","volume":"6","author":"Safaeian","year":"2013","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"10.1016\/j.jcv.2016.09.011_bib0140","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/cncr.28626","article-title":"One HPV vaccine dose may prevent cervical cancer","volume":"120","author":"Printz","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.jcv.2016.09.011_bib0145","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5694\/mja14.00021","article-title":"Cervical screening rates for women vaccinated against human papillomavirus","volume":"201","author":"Budd","year":"2014","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.jcv.2016.09.011_bib0150","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/s12879-014-0545-9","article-title":"Exploring reasons for non-vaccination against human papillomavirus in Italy","volume":"14","author":"Giambi","year":"2014","journal-title":"BMC Infect. Dis."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653216305443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653216305443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T13:26:53Z","timestamp":1601126813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653216305443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":30,"alternative-id":["S1386653216305443"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2016.09.011","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of HPV vaccination in women reaching screening age in Italy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2016.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}